Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 980 of 6351
-
Better sleep, better blood sugar? a trial puts sleep coaching to the test
Disease control CompletedUp to 40% of adults with type 1 diabetes have insufficient sleep which is associated with negative health consequences including poor blood glucose control and greater diabetes complications. In this study, a sleep intervention (Sleep-Opt) that uses wearable sleep tracking techno…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Promising drug cocktail targets tough blood cancers
Disease control OngoingThis phase I/II trial studies the side effects and best dose of venetoclax in combination with cedazuridine and decitabine (ASTX727) in treating patients with high risk myelodysplastic syndrome or chronic myelomonocytic leukemia who have not received prior treatment (treatment-na…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill combo shows promise for Hard-to-Treat lung cancer mutation
Disease control OngoingA Phase II study of the BRAF inhibitor Encorafenib in combination with the MEK inhibitor Binimetinib in Patients with BRAFV600E-mutant metastatic Non-small Cell Lung Cancer
Phase 2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a pill and a vaccine stop STIs in High-Risk men?
Prevention CompletedThe study ANRS 174 Doxyvac is a clinical trial that will use Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex with Men and using oral TDF/FTC for HIV Pre-Exposure Prophylaxis (PrEP) and vaccination with Bexsero.
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
New hope for tough lymphoma: targeted drug combo shows promise in early trial
Disease control OngoingThis phase II trial studies the effect of polatuzumab vedotin, rituximab, ifosfamide, carboplatin, and etoposide as initial salvage therapy in treating patients with diffuse large B-cell lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Polatuz…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 26, 2026 12:54 UTC
-
Personalized cancer attack: new trial matches drugs to tumor genes
Disease control OngoingTAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastati…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a tiny dose of a common blood thinner protect hearts in kidney failure?
Disease control CompletedThe TRACK trial is an investigator-initiated, multicentre, prospective, randomised, quadruple-blind (participant, healthcare provider, data collector, outcomes assessor), placebo-controlled trial. TRACK is a global trial and will be conducted in renal units that provide comprehen…
Phase 3 • Sponsor: The George Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart study tests if lowering 'Bad' cholesterol even more saves lives
Disease control CompletedAlthough the clinical efficacy of LDL-cholesterol lowering therapy has been proven with strong evidences and emphasized, there are also growing concerns that intensive lipid-lowering therapy would be related to increased risk of adverse effects. In addition, statin potency from r…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental gene therapy targets Tay-Sachs and sandhoff in kids
Disease control Stopped earlyThe AXO-GM2-001 study is an open-label, two-stage clinical trial designed to evaluate safety and dose-escalation (Stage 1) and safety and efficacy (Stage 2) of a bilateral thalamic and intracisternal/intrathecal infusion of AXO-AAV-GM2 in pediatric participants with GM2 Gangliosi…
Phase 1 • Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC
-
New hope for kids with severe eczema: dupilumab shows promise in japanese trial
Disease control CompletedPrimary Objective: To evaluate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) Secondary Objective: To evaluate the efficacy of dupilumab administered concomitantly with TCS. To assess the safety of dupilumab over 16 weeks of treatment w…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 16:14 UTC
-
New hope for kids with migraines: rimegepant enters final testing
Symptom relief Recruiting nowThe purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
Phase 3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can family therapy prevent psychosis in At-Risk youth?
Disease control OngoingThe present study is a confirmatory efficacy trial of Family Focused Therapy for youth at clinical high risk for psychosis (FFT-CHR). This trial is sponsored by seven mature CHR clinical research programs from the North American Prodrome Longitudinal Study (NAPLS). The young clin…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Scientists hunt for pancreatic cancer signs in waste fluid
Diagnosis Recruiting nowPancreatic ductal adenocarcinoma (PDAC) remains among cancers with a very poor prognosis (1-year survival \<20%). Endoscopic ultrasound with fine needle aspiration (EUS/FNA) is the common examination for all patients with suspicious pancreatic mass. A method was recently develope…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Blood test could cut lung cancer diagnosis time
Diagnosis OngoingThis study will assess the utility of liquid biopsy to accelerate the time to treatment for patients with newly diagnosed advanced non-small cell lung cancer, compared to the conventional diagnostic pathway of molecular testing of tumour tissue after imaging and biopsy.
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Groundbreaking trial could spare thousands of breast cancer patients from unnecessary surgery
Disease control OngoingCurrently, axillary surgery for breast cancer is considered as staging procedure that does not seem to influence breast cancer mortality, since the risk of developing metastasis depends mainly on the biological behaviour of the primary (seed-and-soil model). Based on this, the po…
Sponsor: Toralf Reimer, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy aims to stop lung cancer return after surgery
Disease control OngoingThis is an open-label, randomised, two-arm, phase III, multi-centre clinical trial. 210 stage IB-IIIA, completely resected, non-small cell lung cancer patients will be enrolled in this trial to evaluate the disease free survival between experimental arm (Adjuvant Chemotherapy-Im…
Phase 3 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug shows promise in advanced bladder cancer battle
Disease control CompletedThe primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC).
Phase 3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy offers hope for frail lung cancer patients
Disease control OngoingThis phase II trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kil…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Immunotherapy combo shows promise in Tough-to-Treat anal cancer
Disease control CompletedThis study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a One-Day catheter beat the stent for kidney stone recovery?
Disease control Recruiting nowSeveral studies evaluated the benefit of a short-term external ureteral catheter (UC) compared to double-J (DJ) ureteral stent after flexible ureteroscopy (URS); the results were controversial. These studies had combined analyses of ureteral and renal stones with a high risk of s…
Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC